Jeff Yass’s Oramed Pharmaceuticals ORMP Stock Holding History
Bought
Maintained
Sold
Other funds holding ORMP
GIA
BCM
Jeff Yass's ORMP Position: Q3 2026 in Review
Jeff Yass sold out of Oramed Pharmaceuticals (ORMP) in Q3 2026, closing a stake of 22,300 shares — an estimated $101K sold.
Jeff Yass first reported a position in ORMP in Q1 2014 and held it in 31 quarters. The position peaked at $2.23M in Q4 2022. 87 funds tracked by Wall St. Rank hold ORMP as of Q3 2026.
- Jeff Yass reported no remaining Oramed Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
- Jeff Yass sold 22,300 Oramed Pharmaceuticals shares in Q3 2026, an estimated $101K.
- Jeff Yass first reported a position in Oramed Pharmaceuticals in Q1 2014 and held it in 31 quarters.
- Jeff Yass's Oramed Pharmaceuticals position peaked at $2.23M in Q4 2022.
- 87 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.